Liposaccharide natural compounds consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria).
Chemical ID:
MESH:D008070
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; 7-Ala-angiotensin (1-7) inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; [Lead co-treated with Lipopolysaccharides] results in increased phosphorylation of MAPK1 protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein; [Lipopolysaccharides co-treated with IFNG] results in increased phosphorylation of MAPK1 protein; ADRB2 protein promotes the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]]; Albuterol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein]; alisol B 23-acetate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Cysteine analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; ICI 118551 inhibits the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]]; Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein; Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; MAPK1 protein promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Simvastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]; triptolide inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
Lipopolysaccharides results in increased expression of MAPK1 mRNA; Lipopolysaccharides results in increased expression of MAPK1 protein; Lipopolysaccharides results in increased expression of MAPK1 protein modified form
1,6-hexamethylene diisocyanate promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; 2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; [Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK1 protein; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; acetovanillone inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK1 protein]; acetovanillone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK1 protein]; arctigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; CRT 0066101 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK1 protein]; eupafolin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Genistein inhibits the reaction [Lipopolysaccharides affects the localization of and results in increased phosphorylation of MAPK1 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; herbimycin inhibits the reaction [Lipopolysaccharides affects the localization of and results in increased phosphorylation of MAPK1 protein]; honokiol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Lipopolysaccharides affects the localization of and results in increased phosphorylation of MAPK1 protein; Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein; Particulate Matter analog affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; PGGT1B inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; phillygenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; RHOA mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Simvastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Vehicle Emissions analog affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Y 27632 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
17-hydroxyjolkinolide B inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; 2-chloro-4'-methoxychalcone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; [[PTPN6 protein results in increased phosphorylation of MAPK1 protein] which results in increased activity of CEBPB protein] promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK1 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; [Curcumin binds to 4-bis(2-chloroethyl)aminobenzaldehyde] inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; [Drugs, Chinese Herbal co-treated with niuhuang] promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of MAPK1 protein modified form; [Lead co-treated with Lipopolysaccharides] results in increased phosphorylation of MAPK1 protein; [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of MAPK1 protein modified form; [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein; [Lipopolysaccharides co-treated with IFNG] results in increased phosphorylation of MAPK1 protein; [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; AG 127 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; alisol B 23-acetate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; arctigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; arctiin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of MAPK1 protein modified form]; Bee Venoms inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form]; Caffeine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]; capsazepine inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]; Carbenoxolone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; CD14 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; CRT 0066101 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Cryptoxanthins inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; cynatratoside-C inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; EIF2AK2 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; ethyl pyruvate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Folic Acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; fructose-1,6-diphosphate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; fucoxanthin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of MAPK1 protein modified form]; Ginkgo biloba extract inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; goniothalamin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; GW 506033X inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; hinokiflavone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; isoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; ITGAM protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; juzentaihoto inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; kaempferol 7-O-glucoside inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form]; Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Lentinan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Lipopolysaccharides inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein]; Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK1 mRNA]; Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK1 protein]; Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein; lipoxin A4 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Lithium promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Luteolin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; MAP3K8 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; MAPK1 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; matairesinol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Melitten inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein]; methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; MK615 extract inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Niclosamide inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; patchouli alcohol inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form]; phlorofucofuroeckol A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form]; Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK1 mRNA]; Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein]; Pyrazines inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; resiniferatoxin inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; scolymoside inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; Silymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of MAPK1 protein modified form]; soyasaponin Ab inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; trametinib inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; VAV1 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; vitisin A inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form]; wogonin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; Wortmannin inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
